Verbal Synchrony, Satisfaction and Decision-making in Face-to-face Consultations

Launched by EUROPEAN INSTITUTE OF ONCOLOGY · Mar 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how patients with benign thyroid nodules communicate and make decisions during face-to-face consultations with their doctors. The goal is to see how well patients understand their treatment options when they talk with their endocrinologist, surgeon, or radiologist. By recording these conversations, researchers hope to learn more about the relationship between patient satisfaction and effective communication.

To participate in this study, you need to be at least 18 years old, have been diagnosed with a benign thyroid nodule, and have a scheduled appointment with one of the specialists mentioned. It's also important that you can speak and understand Italian well, as the consultations will be recorded in that language. Patients with certain mental or neurological disorders that could affect their participation will not be included. If you decide to join, you can expect to engage in a regular consultation while contributing to valuable research that may improve communication between patients and doctors in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Specifically, to be eligible for the inclusion in this study, each patient has to fulfill all these criteria:
• • diagnosis of benign thyroid nodule;
• • scheduled consultation with endocrinologist and/or surgeon and/or radiologist to discuss treatment options related to benign thyroid nodule;
• • ≥18 years old at the time of recruitment;
• • proper understanding of Italian language;
• • fluent Italian speaker;
• • able to comply to requested procedures to obtain audio-video recording.
• Each professional has to fulfill these criteria:
• • proper understanding of Italian language;
• • fluent Italian speaker;
• • able to comply to requested procedures to obtain audio-video recording.
• Exclusion Criteria:
• • • Patients with diagnosed mental or neurological disorder that could impair the participation will be excluded from the study.